UBS O'Connor’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-54,035
Closed -$97K 633
2022
Q3
$97K Buy
+54,035
New +$97K ﹤0.01% 810